J Am Dent Assoc. 2023 Aug;154(8):727-741.e10. doi: 10.1016/j.adaj.2023.04.018.
Corticosteroids are used to manage pain after surgical tooth extractions. The authors assessed the effect of corticosteroids on acute postoperative pain in patients undergoing surgical tooth extractions of mandibular third molars.
The authors conducted a systematic review and meta-analysis. The authors searched the Epistemonikos database, including MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and the US clinical trials registry (ClinicalTrials.gov) from inception until April 2023. Pairs of reviewers independently screened titles and abstracts, then full texts of trials were identified as potentially eligible. After duplicate data abstraction, the authors conducted random-effects meta-analyses. Risk of bias was assessed using Version 2 of the Cochrane Risk of Bias tool and certainty of the evidence was determined using the Grading of Recommendations Assessment, Development and Evaluation approach.
Forty randomized controlled trials proved eligible. The evidence suggested that corticosteroids compared with a placebo provided a trivial reduction in pain intensity measured 6 hours (mean difference, 8.79 points lower; 95% CI, 14.8 to 2.77 points lower; low certainty) and 24 hours after surgical tooth extraction (mean difference, 8.89 points lower; 95% CI, 10.71 to 7.06 points lower; very low certainty). The authors found no important difference between corticosteroids and a placebo with regard to incidence of postoperative infection (risk difference, 0%; 95% CI, -1% to 1%; low certainty) and alveolar osteitis (risk difference, 0%; 95% CI, -3% to 4%; very low certainty).
Low and very low certainty evidence suggests that there is a trivial difference regarding postoperative pain intensity and adverse effects of corticosteroids administered orally, submucosally, or intramuscularly compared with a placebo in patients undergoing third-molar extractions.
皮质类固醇被用于管理拔牙术后的疼痛。作者评估了皮质类固醇对接受下颌第三磨牙手术拔牙的患者急性术后疼痛的影响。
作者进行了系统评价和荟萃分析。作者检索了 Epistemonikos 数据库,包括 MEDLINE、Embase、Cochrane 对照试验中心注册库和美国临床试验注册处(ClinicalTrials.gov),检索时间从建库至 2023 年 4 月。两名评审员独立筛选标题和摘要,然后确定潜在符合条件的试验全文。在重复数据提取后,作者进行了随机效应荟萃分析。使用 Cochrane 风险偏倚工具版本 2 评估风险偏倚,并使用推荐评估、制定和评价方法确定证据的确定性。
40 项随机对照试验被证明符合条件。证据表明,与安慰剂相比,皮质类固醇在术后 6 小时(平均差异,低 8.79 分;95%CI,低 14.8 至 2.77 分;低确定性)和 24 小时(平均差异,低 8.89 分;95%CI,低 10.71 至 7.06 分;极低确定性)时提供了轻微的疼痛强度降低。作者发现皮质类固醇与安慰剂在术后感染(风险差异,低 0%;95%CI,低 1%至 1%;低确定性)和牙槽骨炎(风险差异,低 0%;95%CI,低 3%至 4%;极低确定性)的发生率方面没有显著差异。
低确定性和极低确定性证据表明,与安慰剂相比,接受皮质类固醇(口服、黏膜下或肌内给予)的患者在第三磨牙拔除术后疼痛强度和不良反应方面存在轻微差异。